Literature DB >> 6202353

An increase in sensitivity of rat cingulate cortical neurones to substance P occurs following withdrawal of chronic administration of antidepressant drugs.

R S Jones, H R Olpe.   

Abstract

The sensitivity of neurones in the cingulate cortex of the rat to iontophoretically applied substance P (SP) was tested one hour after a single dose of various antidepressant drugs and also 1 day following the termination of a chronic dosing schedule (14 once daily injections) of the same agents. One hour after a single injection of desipramine (DMI), chlorimipramine (CMI), trimipramine (TMI) or zimelidine ( ZIM ) (all at 10 mg kg-1 i.p.) there was no change in the mean size of excitatory responses to SP compared to those before the injection. There was a tendency towards a decrease in the TMI group. One day following the last of 14 consecutive daily injections (10 mg kg-1 i.p.) of the above agents there was a significant increase in the size of excitatory responses to SP compared to those in rats receiving daily saline injections. However, 14 days of treatment with DMI did not alter the responses to L-glutamate. Similar chronic dosing schedules with either diazepam (5 mg kg-1) or fluphenazine (5 mg kg-1) did not affect the responses to SP. Thus chronic but not acute administration of antidepressant drugs results in an increase in the sensitivity of neurones, in the cingulate cortex of the rat, to SP.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6202353      PMCID: PMC1986914          DOI: 10.1111/j.1476-5381.1984.tb16132.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  18 in total

1.  The monoamine innervation of rat cerebral cortex: synaptic and nonsynaptic axon terminals.

Authors:  A Beaudet; L Descarries
Journal:  Neuroscience       Date:  1978       Impact factor: 3.590

2.  Distribution of substance P-like immunoreactivity in the central nervous system of the rat--II. Light microscopic localization in relation to catecholamine-containing neurons.

Authors:  A Ljungdahl; T Hökfelt; G Nilsson; M Goldstein
Journal:  Neuroscience       Date:  1978       Impact factor: 3.590

Review 3.  The catecholamine hypothesis of affective disorders: a review of supporting evidence.

Authors:  J J Schildkraut
Journal:  Am J Psychiatry       Date:  1965-11       Impact factor: 18.112

4.  Adaptive changes in catecholamine receptors in the central nervous system.

Authors:  T Reisine
Journal:  Neuroscience       Date:  1981       Impact factor: 3.590

5.  Reduced sensitivity of neurons to noradrenaline after chronic treatment with antidepressant drugs.

Authors:  H R Olpe; A Schellenberg
Journal:  Eur J Pharmacol       Date:  1980-04-11       Impact factor: 4.432

6.  Differential actions of mianserin and iprindole on the sensitivity of cortical neurons to noradrenaline: effect of chronic treatment.

Authors:  H R Olpe; A Schellenberg; M W Steinmann
Journal:  Eur J Pharmacol       Date:  1981-07-10       Impact factor: 4.432

7.  Trimipramine: twenty years' worldwide clinical experience.

Authors:  E C Settle; F J Ayd
Journal:  J Clin Psychiatry       Date:  1980-08       Impact factor: 4.384

8.  5-Hydroxytryptamine reduces substance P responses on dorsal horn interneurones: a possible interaction of neurotransmitters.

Authors:  J E Davies; M H Roberts
Journal:  Brain Res       Date:  1981-08-03       Impact factor: 3.252

9.  The sensitivity of cortical neurons to serotonin: effect of chronic treatment with antidepressants, serotonin-uptake inhibitors and monoamine-oxidase-blocking drugs.

Authors:  H R Olpe; A Schellenberg
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575

Review 10.  Chronic antidepressant therapy and associated changes in central monoaminergic receptor functioning.

Authors:  M F Sugrue
Journal:  Pharmacol Ther       Date:  1983       Impact factor: 12.310

View more
  1 in total

1.  Responses of limbic and extrapyramidal substance P systems to nicotine treatment.

Authors:  Mario E Alburges; Paul S Frankel; Amanda J Hoonakker; Glen R Hanson
Journal:  Psychopharmacology (Berl)       Date:  2008-09-05       Impact factor: 4.530

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.